steatohepatitis nash

Patients with nonalcoholic steatohepatitis (NASH) are candidates for liver transplants, but may be at increased risk of complications from metabolic syndrome, researchers say.

(Wiley-Blackwell) Researchers at the University of Miami School of Medicine compared the outcomes of cirrhotic patients who underwent liver transplants for nonalcoholic steatohepatitis (NASH) versus alcoholic liver disease (ETOH) and found no statistically significant differences in post-transplant survival rates between the NASH and ETOH groups.

Study findings are presented in the December issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.